CIK 0001274737
- Non-accelerated filer
- Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 760-560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- Open-market buys, last 90 days
- $568,660
- in 3 filings
- Open-market sales, last 90 days
- $1,233,534
- in 4 filings
Net −$664,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-01 | Zack Debra Chief Medical Officer | Shares withheld for taxes | −3,241 | $7.12 | $23K | 84,259 |
| 2022-02-04 | Zack Debra Chief Medical Officer | Grant or award | +50,000 | 87,500 | ||
| 2021-02-23 | Zack Debra Chief Medical Officer | Grant or award | +37,500 | 37,500 | ||
| 2021-02-23 | Zack Debra Chief Medical Officer | Grant or award · Stock Option(right to buy) | +12,500 | 12,500 | ||
| 2020-03-24 | Zack Debra Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 1 of 1 · 5 trades